Clinical Trial Update: Cost-effectiveness Analysis Between Two Anticoagulation Strategies for Atrial Fibrillation in the Postoperative Period of Coronary Artery Bypass Graft Surgery [Phase 4]

View source ↗

Summary

Phase 4 cost-effectiveness analysis comparing two anticoagulation strategies for new-onset atrial fibrillation after coronary artery bypass graft surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Fibrillation After Surgery

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Atrial Fibrillation New Onset | Phase 4 | Status: UNKNOWN